Integra Stock Dips on Lowered Guidance
Integra LifeSciences (Nasdaq: IART) shares fell after reporting third-quarter results that missed consensus forecasts.
Shares of IART dropped over 8% to $14.15 after the market opened. The company reported a loss of $5.4 million, or 7¢ per share, on sales of $402.1 million.
- Adjusted earnings per share: 54¢, exceeding expectations by 11¢
- Sales: $402.1 million, short of the projected $414.3 million
- Codman Specialty Surgical business: 70% of revenue, $292 million
“supply interruptions”
The company attributed the sales shortfall to supply interruptions.
Author's summary: Integra LifeSciences' stock dips due to lowered guidance.
More News
- Halloween decorating contest winners announced
- Disney Ended Doctor Who Partnership for These 3 Reasons
- NBA approves $10 billion Lakers sale to Mark Walter
- Teacher pay: DfE suggests 6.5% rise - but over three years
- The Knicks are seeing the true value of Miles McBride during his absence
- Thriving providers are not the ones performing for Ofsted
- Shares of Navan Down 16% In Long-Awaited IPO Debut
- A Journey Through the Arab World’s Most Beloved Breads
- CNN announces election night coverage plans, including All Access-only ‘livecast’
- Homestead preschool teacher accused of pushing and grabbing 3-year-old faces judge - WSVN 7News | Miami News, Weather, Sports | Fort Lauderdale